share_log

Evelo Biosciences | EFFECT: Others

SEC ·  Mar 11, 2024 10:06

Summary by Futu AI

The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.
The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for Evelo Biosciences, Inc. The notice, which signifies that a submission by the company has been accepted and is now effective, was dated March 8, 2024. The submission type was POS AM, with an accession number of 0001193125-24-016886. Evelo Biosciences, identified by CIK 0001694665, had filed under the number 333-273869.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 215

Recommended